Literature DB >> 8618898

Liver-specific expression of the human factor VII gene.

D Greenberg1, C H Miao, W T Ho, D W Chung, E W Davie.   

Abstract

Promoter and silencer elements of the immediate 5' flanking region of the gene coding for human factor VII were identified and characterized. The major transcription start site, designated as +1, was determined by RACE (rapid amplification of cDNA ends) analysis of human liver cDNA and was found to be located 50 bp upstream from the translation start site. Two minor transcription start sites were found at bp +32 bp and +37. Progressive deletions of the 5' flanking region were fused to the chloramphenicol acetyltransferase reporter gene and transient expression in HepG2 and HeLa cells was measured. Two promoter elements that were essential for hepatocyte-specific transcription were identified. The first site, FVIIP1, located at bp -19 to +1, functioned independently of orientation or position and contributed about one-third of the promoter activity of the factor VII gene. Electrophoretic mobility-shift, competition, and anti-hepatocyte nuclear factor 4 (HNF4) antibody supershift experiments demonstrated that this site contained an HNF-4 binding element homologous to the promoters in the genes coding for factor IX and factor X. The second site, FVIIP2, located at bp -50 to -26, also functioned independent of orientation or position and contributed about two thirds of the promoter activity in the gene for factor VII. Functional assays with mutant sequences demonstrated that a 10-bp G + C-rich core sequence which shares 90% sequence identity with the prothrombin gene enhancer was essential for the function of the second site. Mobility-shift and competition assays suggested that this site also binds hepatic-specific factors as well as the transcription factor Sp1. Two silencer elements located upstream of the promoter region spanning bp -130 to -103 (FVIIS1 site) and bp -202 to -130 (FVIIS2) were also identified by reporter gene assays.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8618898      PMCID: PMC40354          DOI: 10.1073/pnas.92.26.12347

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

Authors:  P J Mitchell; R Tjian
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

2.  Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation.

Authors:  P J O'Hara; F J Grant; B A Haldeman; C L Gray; M Y Insley; F S Hagen; M J Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  DBP, a liver-enriched transcriptional activator, is expressed late in ontogeny and its tissue specificity is determined posttranscriptionally.

Authors:  C R Mueller; P Maire; U Schibler
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

4.  Functional characterization of the 5'-regulatory region of human factor IX gene.

Authors:  J P Salier; S Hirosawa; K Kurachi
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

5.  PCR-based cDNA library construction: general cDNA libraries at the level of a few cells.

Authors:  A Belyavsky; T Vinogradova; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

6.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.

Authors:  M A Frohman; M K Dush; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

8.  Control of granulocyte-macrophage colony-stimulating factor production in normal endothelial cells by positive and negative regulatory elements.

Authors:  K Kaushansky
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

9.  A general method of site-specific mutagenesis using a modification of the Thermus aquaticus polymerase chain reaction.

Authors:  R M Nelson; G L Long
Journal:  Anal Biochem       Date:  1989-07       Impact factor: 3.365

10.  Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells.

Authors:  L Thim; S Bjoern; M Christensen; E M Nicolaisen; T Lund-Hansen; A H Pedersen; U Hedner
Journal:  Biochemistry       Date:  1988-10-04       Impact factor: 3.162

View more
  5 in total

Review 1.  Regulatory polymorphisms underlying complex disease traits.

Authors:  Julian C Knight
Journal:  J Mol Med (Berl)       Date:  2004-12-09       Impact factor: 4.599

2.  Hepatocyte nuclear factor-4-independent synthesis of coagulation factor VII in breast cancer cells and its inhibition by targeting selective histone acetyltransferases.

Authors:  Shiro Koizume; Naho Yokota; Etsuko Miyagi; Fumiki Hirahara; Yoshiyasu Nakamura; Yuji Sakuma; Akira Yoshida; Yoichi Kameda; Eiju Tsuchiya; Wolfram Ruf; Yohei Miyagi
Journal:  Mol Cancer Res       Date:  2009-12-08       Impact factor: 5.852

Review 3.  Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 4.  Tissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  Biomark Cancer       Date:  2015-09-06

5.  A CpG mutational hotspot in a ONECUT binding site accounts for the prevalent variant of hemophilia B Leyden.

Authors:  Alister P W Funnell; Michael D Wilson; Benoit Ballester; Ka Sin Mak; Jon Burdach; Natisha Magan; Richard C M Pearson; Frederic P Lemaigre; Kathryn M Stowell; Duncan T Odom; Paul Flicek; Merlin Crossley
Journal:  Am J Hum Genet       Date:  2013-03-07       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.